Mimetas
Leiden
About Mimetas
MIMETAS develops predictive Organ-on-a-Chip cell culture models for better, more reliable and tailored medicines. A significant gap exist between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlates featuring organotypic screening models that have an improved predictability and can be screened at a high throughput.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $32.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2019)
- Website: mimetas.com
- Phone: (318) 588-8316
Industries & Categories
3D Technology, Biotechnology, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/mimetas-67388 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.